The Research Department of Reproductive Health hosts a multidisciplinary team of clinicians and scientists with expertise in a wide range of disorders affecting women's reproductive health. Our research portfolio spans molecular investigation into the health of oocytes (eggs) and embryos, through clinical research of common gynecological conditions, such as endometriosis and polycystic ovarian syndrome, and rare disorders of sexual development, to public health issues such as pre-conception health and control of sexually transmitted infections.
Gynaecological development and function is an umbrella group comprising several teams researching into different benign gynaecological conditions.
Our research focuses on the many aspects of sexual and reproductive health care from use of contraception and the prevention of sexually transmitted infections to pregnancy planning and healthcare before and after pregnancy.
Paul Hardiman leads clinical and laboratory based research programmes in reproductive medicine. He has a major interest in polycystic ovary syndrome, the commonest cause of anovulatory infertility and a major risk factor for type 2 diabetes.
The team are investigating factors that affect preimplantation development, using both human and mouse embryos, and ways of determining the healthiest gametes and embryos.
Our research seeks to understand the underlying genetic causes for infertility with the aim of helping couples undergoing assisted reproduction select embryos that are likely to lead to birth of a healthy child.
The main objective of our research is to better understand the pathophysiology of placental-related diseases of pregnancy with the aim of improving their diagnosis, management and outcome.
The UCL/UCH Centre for Human Reproduction brings together the expertise of clinicians and researchers working in reproductive health at UCL and UCH.